Entity Details

Primary name GNPTA_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ3T906
EntryNameGNPTA_HUMAN
FullNameN-acetylglucosamine-1-phosphotransferase subunits alpha/beta
TaxID9606
Evidenceevidence at protein level
Length1256
SequenceStatuscomplete
DateCreated2006-03-07
DateModified2021-06-02

Ontological Relatives

GenesGNPTAB

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0003976 UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity
GO:0005509 calcium ion binding
GO:0005794 Golgi apparatus
GO:0007040 lysosome organization
GO:0016021 integral component of membrane
GO:0016256 N-glycan processing to lysosome
GO:0033299 secretion of lysosomal enzymes
GO:0046835 carbohydrate phosphorylation

Subcellular Location

Show/Hide Table
Subcellular Location
Golgi apparatus membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000800 Notch domainDomainDomain
IPR002048 EF-hand domainDomainDomain
IPR010506 DMAP1-binding domainDomainDomain
IPR018247 EF-Hand 1, calcium-binding siteSiteBinding site
IPR021520 Stealth protein CR2, conserved region 2DomainDomain
IPR031356 Stealth protein CR4, conserved region 4DomainDomain
IPR031357 Stealth protein CR3, conserved region 3DomainDomain
IPR031358 Stealth protein CR1, conserved region 1DomainDomain
IPR035993 Notch-like domain superfamilyFamilyHomologous superfamily
IPR041536 N-acetylglucosamine-1-phosphotransferase subunit alpha/beta, regulatory domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
252500 OMIMMucolipidosis type II (MLII)Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. The disease is caused by variants affecting the gene represented in this entry.
252600 OMIMMucolipidosis type III complementation group A (MLIIIA)Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. The disease is caused by variants affecting the gene represented in this entry.

Interactions

8 interactions